Bansal Wire IPO vs Emcure Pharma IPO

Comparision between Bansal Wire IPO and Emcure Pharma IPO.

IPO Details

Bansal Wire IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Emcure Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Bansal Wire IPO	Emcure Pharma IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	SBI Capital Markets Limited Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd)	Kotak Mahindra Capital Company Limited Axis Capital Limited Jefferies India Private Limited J.P. Morgan India Private Limited
Registrar	Kfin Technologies Limited	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP
Anchor Investor
IPO Allotment URL

Issue Size and Price

The total issue size of Bansal Wire IPO is up to ₹745.00 Cr whereas the issue size of the Emcure Pharma IPO is . The final issue price of Bansal Wire IPO is and of Emcure Pharma IPO is .

	Bansal Wire IPO	Emcure Pharma IPO
Face Value	₹5 per share	₹10 per share
Issue Price (Lower)	₹243.00 per share
Issue Price (Upper)	₹256.00 per share
Issue Price (Final)
Discount (Retail)
Discount (Employee)
Market Lot Size	58 shares
Fresh Issue Size	2,91,01,562 shares
Fresh Issue Size (Amount)	up to ₹745.00 Cr	up to ₹800.00 Cr
OFS Issue Size		1,36,78,839 shares
OFS Issue Size (Amount)
Issue Size Total	2,91,01,562 shares
Issue Size Total (Amount)	up to ₹745.00 Cr

IPO Timetable

Bansal Wire IPO opens on Jul 03, 2024, while Emcure Pharma IPO opens on . The closing date of Bansal Wire IPO and Emcure Pharma IPO is Jul 05, 2024, and , respectively.

	Bansal Wire IPO	Emcure Pharma IPO
Anchor Bid Date	Jul 02, 2024
Issue Open	Jul 03, 2024
Issue Close	Jul 05, 2024
Basis Of Allotment (Tentative)	Jul 08, 2024
Initiation of Refunds (Tentative)	Jul 09, 2024
Credit of Share (Tentative)	Jul 09, 2024
Listing date (Tentative)	Jul 10, 2024
Anchor Lockin End date 1	Aug 07, 2024
Anchor Lockin End date 2	Oct 06, 2024

Financials

Bansal Wire IPO P/E ratio is 41.41, as compared to Emcure Pharma IPO P/E ratio of .

Bansal Wire IPO

Emcure Pharma IPO

Financial

Bansal Wire Industries Limited Financial Information (Restated)

Bansal Wire Industries Limited's revenue increased by 1.99% and profit after tax (PAT) rose by 31.48% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	1,264.01	749.05	695.48
Revenue	2,470.89	2,422.57	2,205.07
Profit After Tax	78.80	59.93	57.29
Net Worth	422.37	282.51	223.01
Reserves and Surplus	358.64	273.41	213.91
Total Borrowing	681.14	422.19	413.15
Amount in ₹ Crore

Summary of financial Information (Restated Consolidated)
Particulars	For the year/period ended (₹ in Millions)
	31-March-21	31-March-20	31-March-19
Total Assets	68,073.98	60,040.55	58,104.39
Total Revenue	60,918.06	51,308.60	48,155.90
Profit After Tax	4,185.94	1,006.10	2,029.68

Promoter Shareholding (Pre-Issue)

95.78%

Promoter Shareholding (Post-Issue)

P/E Ratio

41.41

Market Cap

₹4007.83 Cr.

ROE

21.19%%

ROCE

18.46%%

Debt/Equity

1.48

EPS

₹6.18

RoNW

18.27%%

Shares Offered

In the Bansal Wire IPO retail investors (RII) are offered while in Emcure Pharma IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Bansal Wire IPO and in Emcure Pharma IPO.

	Bansal Wire IPO	Emcure Pharma IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB
NII
RII
Employee
Others
Total

Bids Received (Subscription)

Bansal Wire IPO subscribed in total, whereas Emcure Pharma IPO subscribed .

	Bansal Wire IPO	Emcure Pharma IPO
QIB (times)
NII (times)
Big NII (times)
Small NII (times)
RII (times)
Employee (times)
Other (times)
Total (times)

Compare with others

Bansal Wire IPO	Emcure Pharma IPO
Emcure Pharma IPO	Ethos Limited IPO
OLA Electric	Hariom Pipe Industries IPO
Vraj Iron and Steel IPO	Veranda Learning IPO
Aasaan Loans IPO	Uma Exports IPO
Stanley Lifestyles IPO	LIC IPO
	Manyavar IPO
	Delhivery IPO
	AGS Transact IPO
	CMS Info Systems IPO
	Tracxn Technologies IPO

Comments

Add a public comment...